SILO PHARMA, INC. Investment Owned, at Cost
SILO PHARMA, INC. (SILO) had Investment Owned, at Cost of $0 as of 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Notes › Schedule of Investments
us-gaap:InvestmentOwnedAtCost · last filed 2020-03-20
- 2019-12-31: Investment Owned, at Cost $0.00.
- 2019-09-30: Investment Owned, at Cost $0.00.
- 2019-06-30: Investment Owned, at Cost $32.12K.
- 2019-03-31: Investment Owned, at Cost $45.34K.
| Period end | Investment Owned, at Cost |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-20 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 |
| 2019-06-30 | $32.12K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $45.34K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $45.34K 10-K · filed 2020-03-20 |
| 2018-09-30 | $45.54K 10-Q · filed 2018-11-14 |
| 2017-12-31 | $876.36K 10-K · filed 2019-04-04 |
| 2013-12-31 | $131.02K 10-K · filed 2014-03-31 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |